Evidence map›Paper›PMID 41064933›Full record

ArticleJournal of cell science2025

CEP290 deficiency disrupts ciliary axonemal architecture in human iPSC-derived brain organoids.

Melanie Eschment, Olivier Mercey, Ellen M Aarts, Ludovico Perego, Joana Figueiro-Silva, Michelle Mennel, Affef Abidi, Melanie Generali, Anita Rauch, Paul Guichard and 2 more

Abstract read
In one paragraph

Article in Journal of cell science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Melanie EschmentInstitute of Medical Genetics, University of Zurich, Wagistrasse 12, 8952 Schlieren, Switzerland.ORCID 0000-0002-6881-6570
Olivier MerceyUniversity of Geneva, Faculty of Sciences, Department of Molecular and Cellular Biology, 30, quai Ernest-Ansermet, 1211 Geneva 4, Switzerland.ORCID 0000-0001-7931-1642
Ellen M AartsInstitute of Molecular Systems Biology, ETH Zurich, Otto-Stern-Weg 3, 8093 Zürich, Switzerland.ORCID 0000-0001-8714-061X
Ludovico PeregoInstitute of Medical Genetics, University of Zurich, Wagistrasse 12, 8952 Schlieren, Switzerland.ORCID 0009-0005-6833-8168
Joana Figueiro-SilvaInstitute of Medical Genetics, University of Zurich, Wagistrasse 12, 8952 Schlieren, Switzerland.ORCID 0000-0003-3590-1784
Michelle MennelDepartment of Molecular Life Sciences, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland.
Affef AbidiiPSCore Facility, Institute for Regenerative Medicine, University of Zurich, Wagistrasse 12, 8952 Schlieren, Switzerland.ORCID 0000-0002-3383-9473
Melanie GeneraliiPSCore Facility, Institute for Regenerative Medicine, University of Zurich, Wagistrasse 12, 8952 Schlieren, Switzerland.ORCID 0000-0001-8396-3256
Anita RauchInstitute of Medical Genetics, University of Zurich, Wagistrasse 12, 8952 Schlieren, Switzerland.
Paul GuichardUniversity of Geneva, Faculty of Sciences, Department of Molecular and Cellular Biology, 30, quai Ernest-Ansermet, 1211 Geneva 4, Switzerland.ORCID 0000-0002-0363-1049
Virginie HamelUniversity of Geneva, Faculty of Sciences, Department of Molecular and Cellular Biology, 30, quai Ernest-Ansermet, 1211 Geneva 4, Switzerland.ORCID 0000-0001-5092-2343
Ruxandra Bachmann-GagescuInstitute of Medical Genetics, University of Zurich, Wagistrasse 12, 8952 Schlieren, Switzerland.ORCID 0000-0002-3571-5271

Funding

Schweizerischer Nationalfonds zur Furderung der Wissenschaftlichen Forschung 310030_22012Schweizerischer Nationalfonds zur Furderung der Wissenschaftlichen Forschung PP00P3_198895Swiss National Science Foundation 310030_22012Swiss National Science Foundation PP00P3_198895Uniscientia FoundationUniversitat Zurich AdaBDUniversitat Zurich PraeclareUniversity of Zurich AdaBDUniversity of Zurich Clinical Research Priority ProgramUniversity of Zurich PraeclareUniversity of Zurich University Research Priority Program
6 · The paper itself

Abstract

Primary cilia are ubiquitous sensory organelles mediating various signaling modalities essential for development and cell homeostasis. Their dysfunction leads to ciliopathies, human disorders often affecting the central nervous system. CEP290 is a major ciliopathy-associated gene that encodes a centrosomal and ciliary transition zone protein. CEP290 has been implicated in different cellular functions, including cell cycle control, ciliogenesis and control of ciliary membrane protein content. To investigate CEP290 dysfunction in human neurons, we generated human induced pluripotent stem cell (iPSC)-derived brain organoids harboring CEP290 mutations. We found that CEP290 deficiency does not affect cell cycle progression or organoid formation, despite a tendency for less mature neuronal populations and formation of choroid plexus in mutant organoids. Expansion microscopy revealed morphologically abnormal ventricular cilia in the CEP290 mutant organoid cells with bulging ciliary membranes around splayed distal axonemal microtubules. Such ciliary abnormalities might represent a tissue-specific consequence revealed by studying a human neuronal organoid model.

Indexed as

Antigens, NeoplasmAxonemeBrainCell Cycle ProteinsCiliaCytoskeletal ProteinsInduced Pluripotent Stem CellsOrganoidsCiliopathiesHumansMutationNeuronsAntigens, NeoplasmCell Cycle ProteinsCep290 protein, humanCytoskeletal ProteinsBrain organoidsCEP290CiliopathiesNeurodevelopmentPrimary cilium

Identifiers

PMID41064933
PMCPMC12633733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.